The tumor suppressor role of CTCF
- PMID: 21465478
- DOI: 10.1002/jcp.22780
The tumor suppressor role of CTCF
Abstract
CTCF is an evolutionary conserved and ubiquitously expressed protein that binds thousands of sites in the human genome. Ectopic expression of CTCF in various normal and tumoral human cell lines inhibits cell division and clonogenicity, with the consequence to consider CTCF a potential tumor-suppressor factor. In this review article, we focused on the molecular mechanisms engaged by CTCF to modulate the expression of several key-regulators of differentiation, cellular senescence, cell cycle control and progression, whose expression is frequently altered in tumors. Moreover, we discussed common features of CTCF at each tumor-related DNA-binding sequence, such as protein-partners, post-translational modifications, and distinctive epigenetic marks establishment. The investigation of the molecular mechanisms engaged by CTCF to modulate tumor-related genes emphasizes the cell-type dependency of its tumor suppressor role. Indeed, the ability of CTCF to bind their promoters strictly depends by cell-type features as DNA methylation, BORIS-binding and post-translational modifications as PARYlation.
Copyright © 2011 Wiley Periodicals, Inc.
Similar articles
-
A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers.Genes Chromosomes Cancer. 1998 May;22(1):26-36. Genes Chromosomes Cancer. 1998. PMID: 9591631
-
Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells.Cancer Res. 2005 Sep 1;65(17):7763-74. doi: 10.1158/0008-5472.CAN-05-0823. Cancer Res. 2005. PMID: 16140944
-
Epigenetic regulation of the human p53 gene promoter by the CTCF transcription factor in transformed cell lines.Oncogene. 2010 Apr 15;29(15):2217-27. doi: 10.1038/onc.2009.509. Epub 2010 Jan 25. Oncogene. 2010. PMID: 20101205
-
CTCF and BORIS in genome regulation and cancer.Curr Opin Genet Dev. 2014 Feb;24:8-15. doi: 10.1016/j.gde.2013.10.011. Epub 2013 Dec 14. Curr Opin Genet Dev. 2014. PMID: 24657531 Review.
-
CTCF function is modulated by neighboring DNA binding factors.Biochem Cell Biol. 2011 Oct;89(5):459-68. doi: 10.1139/o11-033. Epub 2011 Sep 7. Biochem Cell Biol. 2011. PMID: 21895576 Review.
Cited by
-
Dose-dependent activation of putative oncogene SBSN by BORIS.PLoS One. 2012;7(7):e40389. doi: 10.1371/journal.pone.0040389. Epub 2012 Jul 5. PLoS One. 2012. PMID: 22792300 Free PMC article.
-
The apoptosis associated tyrosine kinase gene is frequently hypermethylated in human cancer and is regulated by epigenetic mechanisms.Genes Cancer. 2014 Sep;5(9-10):365-74. doi: 10.18632/genesandcancer.28. Genes Cancer. 2014. PMID: 25352953 Free PMC article.
-
CTCF: A misguided jack-of-all-trades in cancer cells.Comput Struct Biotechnol J. 2022 May 27;20:2685-2698. doi: 10.1016/j.csbj.2022.05.044. eCollection 2022. Comput Struct Biotechnol J. 2022. PMID: 35685367 Free PMC article. Review.
-
CircESRP1 inhibits clear cell renal cell carcinoma progression through the CTCF-mediated positive feedback loop.Cell Death Dis. 2021 Nov 13;12(11):1081. doi: 10.1038/s41419-021-04366-4. Cell Death Dis. 2021. PMID: 34775467 Free PMC article.
-
The promoter methylation status and mRNA expression levels of CTCF and SIRT6 in sporadic breast cancer.DNA Cell Biol. 2014 Sep;33(9):581-90. doi: 10.1089/dna.2013.2257. Epub 2014 May 19. DNA Cell Biol. 2014. PMID: 24842653 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources